Security key
83006G203
60 Degrees Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (SXTP)
CUSIP: 83006G203
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 500
- Total 13F value
- $645
- Share change
- +500
- SEC-reported price per share
- $1.29
- Number of holders
- 1
- Value change
- +$645
- Number of buys
- 1
- Shares outstanding
- 2,827,300
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
1
Top holders
0
SXTP full security history
Ownership snapshot
60 DEGREES PHARMACEUTICALS, INC. SEC filings
60 DEGREES PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of SXTP - 60 Degrees Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
8/15
Latest evidence
03 Jun 2025
13D/G
3/4/5
13F
Lead comparable stake: 5%
7 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
Cheryl Xu
0.37%
UBS Group AG
0.38%
GEODE CAPITAL MANAGEMENT, LLC
0.28%
Tower Research Capital LLC (TRC)
0.04%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$226,656
77,357 shares
|
$0 | 31 Mar 2025 |
| Cheryl Xu |
3/4/5
Director
|
0.37%
|
$45,866
15,816 shares
|
— | 03 Jun 2025 |
| UBS Group AG |
13F
Company
|
0.38%
|
$29,786
16,188 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.28%
|
$21,463
11,924 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.04%
|
$2,852
1,550 shares
|
— | 31 Mar 2025 |
| Safe Harbor Fiduciary, LLC |
13F
Company
|
0.01%
|
$506
275 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Archived quarter
Historical 13F summary for Q2 2025
This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.